Company / Cash per Share
Zai Lab Ltd Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.63
FY2025
5-year range
$0.46 / $5.03
FY2021-FY2025
Trend
+36.3%
vs FY2024
Sector context
#161 of 205
Health Care
What the data says
Zai Lab Ltd's cash per share of $0.63 is lower than 79% of companies in the Health Care sector (FY2025). Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $0.63.
Based on SEC 10-K filings.
0.63 in FY2025 with a 5-year CAGR of -10.7%.
Declined from $0.82 to $0.63 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -14.5%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 205This company $0.63 Sector average $72.93
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 36.3% year-over-year.
- Ranks #161 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | +36.3% |
| FY2024 | $0.46 | -43.8% |
| FY2023 | $0.82 | -18.5% |
| FY2022 | $1.01 | -79.9% |
| FY2021 | $5.03 | +352.5% |
| FY2020 | $1.11 | -5.7% |
| FY2019 | $1.18 | -1.4% |
| FY2018 | $1.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026